Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetic characteristics of DA414 for ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DA414

Snippet

Sponsor: Chendu DIAO Nine Hong Pharmaceutical Factory | Conditions: Ischemic Stroke | Phase 1 | Status: RECRUITING